Migraine Episodic
📧 Sign up to get email alerts when something new happens for Migraine Episodic.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-09-03Clinical Trial Update: Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention [Phase 4]
Pfizer completed a Phase 4 safety and tolerability study of daily rimegepant for episodic migraine prevention, with results posted.
-
CLINICAL_TRIALS trial_result · 2021-06-15Clinical Trial Update: Study to Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic Migraine [Phase 3]
Phase 3 trial evaluating safety and tolerability of atogepant 60 mg daily for prevention of episodic migraine has completed with posted resu…